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RESEARCH ARTICLE
DC-SIGN mediated internalisation of glycosylated extracellular vesicles from
Schistosoma mansoni increases activation of monocyte-derived dendritic cells
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D. Linh Nguyena, Clarize M. de Korne a, Roman I. Koning c, John J. Tomes d, Karl F. Hoffmann d,
Hermelijn H. Smits a* and Cornelis H. Hokke a*
aDepartment of Parasitology, Leiden University Medical Center, Leiden, Netherlands; bDepartment of Biomolecular Health Sciences, Faculty
of Veterinary Medicine, Utrecht University, Utrecht, Netherlands; cDepartment of Cell & Chemical Biology, Leiden University Medical Center,
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ABSTRACT
Helminths like Schistosoma mansoni release excretory/secretory (E/S) products that modulate host
immunity to enable infection. Extracellular vesicles (EVs) are among these E/S products, yet
molecular mechanisms and functionality of S. mansoni EV interaction with host immune cells is
unknown. Here we demonstrate that EVs released by S. mansoni schistosomula are internalised
by human monocyte-derived dendritic cells (moDCs). Importantly, we show that this uptake was
mainly mediated via DC-SIGN (CD209). Blocking DC-SIGN almost completely abrogated EV
uptake, while blocking mannose receptor (MR, CD206) or dendritic cell immunoreceptor (DCIR,
CLEC4A) had no effect on EV uptake. Mass spectrometric analysis of EV glycans revealed the
presence of surface N-glycans with terminal Galβ1-4(Fucα1-3)GlcNAc (LewisX) motifs, and a wide
array of fucosylated lipid-linked glycans, including LewisX, a known ligand for DC-SIGN.
Stimulation of moDCs with schistosomula EVs led to increased expression of costimulatory
molecules CD86 and CD80 and regulatory surface marker PD-L1. Furthermore, schistosomula
EVs increased expression of IL-12 and IL-10 by moDCs, which was partly dependent on the
interaction with DC-SIGN. These results provide the first evidence that glycosylation of S. mansoni
EVs facilitates the interaction with host immune cells and reveals a role for DC-SIGN and EV-
associated glycoconjugates in parasite-induced immune modulation.
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Schistosoma mansoni is one of the major helminth para-
sites of humans with over 200 million people infected
[1,2]. In the initial phase of infection, schistosome larvae
(cercariae) penetrate the skin of the host and transform
into schistosomula. These schistosomula larvae will
migrate to the circulatory system, develop into adult
worms that mate and lay eggs [3]. S. mansoni can live
up to 10 years in its host because it has developed success-
ful mechanisms to evade immune responses. To establish
this immune evasion, the parasite releases excretory/
secretory (E/S) products that act on the host immune
system [4]. Among these E/S products are extracellular
vesicles (EVs) and evidence is accumulating that parasite-
derived EVs contribute to parasite-host interaction [5].
The molecular composition of EVs from S. mansoni lar-
vae and adult worms life stages has been partially char-
acterized [6–8], but the interaction of their EVs with host
cells remains unexplored.
For schistosomes to initiate and maintain infection,
modulating host innate and adaptive immune
responses is crucial [9]. Mouse models have shown
that cercarial penetration triggers migration of innate
antigen presenting cells (APCs), such as macrophages
and dendritic cells (DCs), towards the skin draining
lymph nodes [10]. These APCs have upregulated cost-
imulatory molecules, like CD86 and major histocom-
patibility complex (MHC) class II, which are
important for initiating adaptive immune responses.
In vitro stimulation of mouse bone marrow-derived
DCs (BMDCs) with E/S from schistosomula shows
a similar pattern: increased costimulatory molecules
and MHC class II expression and increased pro-
inflammatory cytokine release (IL-6, IL-12, and
TNF-α) [11]. Furthermore, cercarial secretions can
upregulate the expression of IL-10 and programmed
death ligand (PD-L)1 and 2 in human monocyte-
derived (mo)DCs, suggesting that the parasite addi-
tionally utilizes regulatory pathways to dampen
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adaptive immune responses [12]. Relatively little is
known about the exact molecular or structural com-
ponents derived from schistosomula that induce
immunomodulatory effects. Thus far, it has been
shown that recombinant tetraspanins, transmembrane
proteins associated to adult worm EVs [13], induce
IL-10 and Th1 cytokine responses by peripheral blood
mononuclear cells [14]. Whether schistosomula EVs
have similar effects on human DCs has not been
investigated.
Studies exploring the molecular content of schisto-
somula E/S have shown that part of the cytokine
responses by mouse macrophages and whole blood of
infected individuals is induced by glycosylated antigens
in the E/S [15,16]. Schistosome glycoconjugates can be
recognized by host pathogen recognition receptors
(PRRs) on APCs, in particular the C-type lectin recep-
tors (CLRs) such as the mannose receptor (MR,
CD206) [17], dectin-1/2 [18], dendritic cell immunor-
eceptor (DCIR, CLEC4A, CD367) [19] and dendritic
cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN,
CD209) [20]. A well-known immunogenic glycan-
motif, Galβ1-4(Fucα1-3)GlcNAc or LewisX (LeX), is
present on glycoproteins in schistosomula and egg
E/S and can be recognized by DC-SIGN [21] as well
as MR [22], leading to different effects depending on
the structural context of the LeX motif. Pathogen-
associated molecular patterns (PAMPs) containing
high-mannose (oligomannose) structures, which form
ligands for MR and DC-SIGN [23] have also been
found on glycoproteins in E/S from schistosomes
[24]. This raises the question whether schistosomula
EVs expose glycans instrumental in targeting to host
immune cells and whether these EV-associated glycans
play a role in modifying subsequent immune
responses. While it is known that mammalian EVs
contain glycoconjugates, publications on the structure
and function of EV glycans are very limited so far
[25–29].
In order to gain insights into the interaction of
schistosome EVs with the immune system we studied
the interaction of schistosomula EVs with human
moDCs and found that the EVs are internalised mainly
via DC-SIGN. We show that N-glycans on the surface
and glycolipids of the EVs contain DC-SIGN ligands,
including LeX. Furthermore, we demonstrate that these
EV preparations increase the activation status of
moDCs, affecting both immunostimulatory and immu-
noregulatory pathways which were partly dependent on
the interaction with DC-SIGN. Our study provides
evidence for a specific CLR-mediated uptake of EVs
that substantiates the importance of EV-associated gly-
coconjugates in pathogen-host interaction.
Materials and methods
Schistosomula culture
Infected Biomphalaria glabrata snails were incubated
in water at 30°C for 2 h to shed cercariae of the Puerto
Rican-strain of S. mansoni by exposure to light. The
collected cercariae in water were stored on ice for 1.5 h
to immobilize them and were subsequently pelleted by
centrifugation at 440 × g. After removal of the super-
natant, 12 mL of pre-warmed (37°C) DMEM
(Dulbecco’s Modified Eagle Medium, high glucose
with L-glutamine, Lonza, Basel, Switzerland) supple-
mented with 200 U/ml penicillin and 200 µg/ml strep-
tomycin (Sigma-Aldrich, St. Louis, MO, USA), was
added to transform the cercariae to schistosomula by
providing mechanical force via pipetting and incubat-
ing for 20 min at 37°C [30]. Cercarial bodies were
separated from their tails using an orbital shaker. The
collected schistosomula were resuspended in DMEM at
a concentration of 7,500 schistosomula/mL and cul-
tured in 25 cm2 polystyrene flasks (Greiner Bio-One,
Alphen a/d Rijn, The Netherlands) at 37°C and 5%
CO2 for 72 h.
EV isolation and staining
Schistosomula E/S products were enriched for EVs
by differential centrifugation as previously described,
with minor modifications [6]. Briefly, the collected
culture supernatant (9–34 mL per culture, 7,500
schistosomula/mL) was centrifuged in 15 mL tubes
(Greiner Bio-One) twice at 500 × g (k-factor
115,790.8) for 2 min (4°C) (SX4750A rotor and an
Allegra X-15 R centrifuge) (Beckman Coulter, Brea,
CA, USA) with low brake to remove remaining para-
sites. To remove any residual debris, the supernatant
was subsequently centrifuged at 700 × g (k-factor
82,764.4) for 20 min (4°C, low brake). Next, an EV-
enriched pellet was obtained by centrifugation of the
supernatant at 31,000 rpm (average around
120,000 × g, k-factor 216.3) for 80 min at 4°C
(max. acceleration and brake), followed by three
wash steps with cold phosphate buffered saline
(PBS) (B. Braun, Melsungen, Germany) in thin-wall
polypropylene tubes using an SW41 Ti rotor and an
Optima ΧE-90 ultracentrifuge (Beckman Coulter).
For binding/uptake experiments, EVs were stained
with PKH26 (Sigma-Aldrich) after the first ultracen-
trifugation step by addition of 80 µL Diluent C to the
resuspended EV-enriched pellet and incubation of
93 µL diluted PKH26 (1.5 µL in 100 µL Diluent C)
for 3 min at RT before addition of 11 mL PBS.
Unconditioned culture medium incubated without
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parasites was processed (and stained) following the
same procedures and was used as (dye) control. EV-
enriched pellets (from 66,300–253,200 schistosomula)
for in vitro experiments were resuspended in 510 µL
PBS, for transmission electron microscopy (TEM)
and glycan analysis in 100 µL PBS, and for cryo
EM in 40 µL PBS. All were stored at −80°C until
further use except for 1 cryo EM sample, which was
processed directly after EV isolation. We have sub-
mitted all relevant data of our experiments to the
EV-TRACK knowledgebase (EV-TRACK ID:
EV190032) [31].
Transmission electron microscopy
EV preparations were generated in Leiden and visualized
by TEM at Aberystwyth University, as described pre-
viously [6]. Briefly, 10 µl of EV-enriched sample was
fixed with an equal volume of 4% glutaraldehyde,
adsorbed onto Formvar/carbon-coated copper grids
(Agar scientific, Stansted, UK) for 40 min, and subse-
quently contrast stained with 2%uranyl acetate (pH 4) for
10 min. Processed samples were then visualized on a Jeol
1010 transmission electron microscope operated at 80
kV. Images were recorded with a Kodak MegaPlus cam-
era Model 1.4i, other than the addition of scale bars, no
further image processing was done. Sizes were measured
by hand using Fiji/ImageJ software [32].
Nanoparticle tracking analysis (NTA)
EV-enriched suspensions were diluted 1:100 in PBS (to
obtain 25–100 particles per frame at camera level 16)
before analysing the concentration and size distribution
by nanoparticle tracking analysis (NTA) using
a NanoSight NS500 (Malvern Panalytical, Malvern, UK)
equipped with an sCMOS camera. For each EV-enriched
pellet, three videos of 30 seconds were recorded on three
different camera levels: 12, 14 and 16. The analysis was
done with NTA3.3 software and a detection threshold of
5. The average particle concentration of nine videos per
EV-enriched sample, after subtraction of the NTA back-
ground data from PBS alone, was used for further experi-
ments. We additionally measured the protein
concentration of the EV-enriched pellets with
microBCA according to the manufacturers protocol
(Pierce, Thermo Fisher Scientific, Waltham, MA, USA).
Cryo electron microscopy
Previously frozen or freshly isolated EV preparations
(EV from 86,00–112,00 schistosomula in 40 µL PBS)
were visualized by cryo EM. Copper EM grids
supporting a carbon film with regularly spaced 2
micron holes (R2/2, Quantifoil, Jena, Germany) were
glow-discharged in air at 0.2 mbar for 2 min at 20 mA
(EMITECH K950X with glow discharger unit). A 3 µL
drop of sample was applied to the grid and transferred
into the environmental chamber of a Leica EM grid
plunger (Leica Microsystems, Wetzlar, Germany) oper-
ating at RT and between 92% and 94% humidity.
Excess sample was blotted away for 1 second using
filter paper (Whatman no.1) and without waiting
plunged into a mixture of ethane/propane (63/37 v/v)
cooled with liquid nitrogen to −193°C. After vitrifica-
tion, grids were stored under liquid nitrogen and trans-
ferred into a cryo holder (type 626, Gatan, Germany).
In total 238 cryo-EM projection images were recorded
by 1 second exposures at spot 5 on a FEI Tecnai F12 at
120 kEV on a 4 k × 4 k CCD camera (Eagle, Thermo
Fisher Scientific) at a magnification of 13,500 ×
(0.85 nm pixel size) and a defocus value ~ −8 microns.
Size measurement was performed by hand using Fiji/
ImageJ software [32]. After removing double images
and images with no EVs, 233 images were used to
measure a total of 1056 EVs, which were subsequently
quantified in segments of 20 nm (i.e. 21–40 nm,
41–60 nm, 61–80 nm … 861–880 nm, 881–900 nm).
Human monocyte-derived dendritic cells (moDCs)
Venous blood of healthy volunteers who provided
informed consent, approved by the Institutional
Review Board of Leiden University Medical Centre,
was used to isolate monocytes and differentiate to
moDCs as previously described [33]. Immature DCs
were harvested on day 5 or 6, counted, seeded at
5 × 104 cells/well in a 96 well flat-bottom plate, and
rested overnight at 37°C and 5% CO2. Subsequently,
cells were stimulated with or without a pre-incubation
of 30 min with 10 mM EGTA (Sigma-Aldrich), 20 µg/
mL αDC-SIGN/CD209 (clone AZN-D1, custom order
without sodium-azide) (Beckman Coulter), 20 µg/mL
αMR/CD206 (clone 15–2) (BioLegend, San Diego, CA,
USA), 20 µg/mL αDCIR/CLEC4A (clone 111F8.04,
Dendritics, Novus Biologicals, Centennial, CO, USA),
and 20 µg/mL mouse IgG1 isotype control (clone
P3.6.2.8.1) (Invitrogen, Thermo Fisher Scientific) in
the presence of αFcgammaR-binding inhibitor
(eBioscience, Invitrogen) and in the presence or
absence of the maturation factors IL-1β (25 ng/mL)
(BioLegend) and TNF-α (50 ng/mL) (Sino Biological,
Beijing, P.R. China) or LPS (100 ng/mL) (InvivoGen,
San Diego, CA, USA). As a positive control for the
αMR, PF-647-labelled recombinant omega-1 was used
[22,34]. EV-enriched pellets were thawed only once
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and several EV batches were pooled before incubation
with the cells (6 × 109 EV/mL or mentioned otherwise).
To investigate the effect of surface de-N-glycosylation,
EVs were incubated with or without peptide
N-glycosidase F (PNGase F) (4 U/100 µL, Roche
Diagnostics, Almere, The Netherlands) at 37°C for
20 h before moDC incubation. Supernatants were col-
lected from >85% CD1a+ cell cultures after 24 h stimu-
lation and IL-6 (Sanquin, Amsterdam, The
Netherlands), IL-10 (BioLegend), and IL-12p70 (BD
Biosciences, Franklin Lakes, NJ, USA) cytokine pro-
duction was determined with ELISA according to the
manufacturers protocols. Stimulated moDCs were
washed, stained, and measured by flow cytometry on
a FACSCanto II (BD Bioscience) and using the follow-
ing antibodies: CD1a-BV421 (clone HI149)
(BioLegend), HLA-DR-APC-eF780 (clone LN3)
(eBioscience), PD-L2/CD273-FITC (clone MIH18)
(Miltenyi Biotec, Bergisch Gladbach, Germany), CD86-
FITC (clone 2331 (FUN-1)), CD40-APC (clone 5C3),
CD80-V450 (clone L307.4), PD-L1/CD274-PE-Cy7
(clone MIH1) (all BD Bioscience) with the addition of
Fc receptor binding inhibitor (eBioscience) and Aqua
live/dead staining (Invitrogen). Flow cytometric mea-
surements were analysed with FlowJo (version 10, BD
Bioscience).
Confocal microscopy
5 × 104 moDCs/chamber were seeded onto poly-
L-lysine (Sigma-Aldrich) coated coverslips of a 4 cham-
ber glass bottom dish (ø35 mm; Greiner Bio-One) for
24 h. Cells were pre-incubated with EGTA or αDC-
SIGN+αFcgammaR-binding inhibitor as described
above, incubated with PKH-labelled schistosomula EV-
enriched pellets for 5 h, subsequently washed, and
treated with Hoechst (Sigma-Aldrich). Images were
taken at 37°C and 5% CO2 on a Leica TCS (true
confocal scanning SP8 WLL (white light laser) micro-
scope (Leica Microsystems). The sequential scanning
mode was applied to image Hoechst (excitation:
405 nm, emission: 420–470 nm) and PKH26 (excita-
tion: 561 nm, emission: 570–630 nm). For imaging the
uptake of EVs, a 63× objective (Leica HC PL APO 63×/
1.40na OIL CS2) was used. The z-stacks were recorded
and maximum projections of the recorded z-stacks
were generated using the Leica software (LAS
X version 1.1.0.12420; Leica Microsystems).
N-glycan and glycolipid-glycan analysis
For the N-glycan analysis, EV-enriched pellets (in PBS)
from >100,000 cultured schistosomula were lyophilized,
resuspended in 100 µL milliQ water, sonicated and subse-
quently reduced and denatured for 10min at 95°Cwith the
addition of SDS and β-mercaptoethanol which were neu-
tralized by adding NP-40 (Sigma-Aldrich). Full details on
N-glycan isolation has been described previously [35].
N-glycans were released by PNGase F (4 U/100 µL) incu-
bation for 24 h at 37°C and cleaned up by collection in the
flow through of reversed phase (RP) C18-cartridges (JT
Baker, Phillipsburg, NJ, USA) followed by isolation on
carbon cartridges (Supelclean ENVI-carb SPE, Sigma-
Aldrich). In addition, directly after isolation, intact EV
preparations in PBS were treated with PNGase F for 24 h
at 37°C to release directly accessible N-glycans (surface
glycans). The total suspension was subsequently trans-
ferred to a thin-wall polypropylene tube and topped up
with PBS. The EVs were pelleted by ultracentrifugation at
42,000 rpm (average around 120,000 × g, k-factor 85.4) for
65min at 4°C (max. acceleration and brake) using aTLS-55
rotor and an Optima TLX (Beckman Coulter). Next, the
supernatant containing the PNGase F released N-glycans
was collected and these N-glycans were isolated with C18-
and carbon-cartridges. The EV-enriched pellet without
PNGase F accessible surface N-glycans was resuspended
in PBS, lyophilized, sonicated, reduced, denatured, and
treated with PNGase F to isolate remaining N-glycans as
above.
For glycolipid-glycans analysis, EV-enriched pellets
were lyophilized, resuspended in milliQ water, soni-
cated, and subjected to extraction with chloroform
and methanol (MeOH). The upper phase was collected
after sonication and centrifugation. Similar volume as
collected was replaced with 50% MeOH and the pre-
vious steps were repeated twice. All collected upper
phases of the extraction were applied to an RP C18-
cartridge and flow-through and wash fractions were
combined and applied to another C18-cartridge.
Glycolipids were eluted from the cartridges with
chloroform/MeOH/water and dried under a flow of
nitrogen. The glycolipids were subsequently dissolved
in 200 µL 50 mM sodium acetate with 0.1% sodium
taurodeoxycholate hydrate (Sigma-Aldrich), sonicated,
and heated to 60°C for 10 min. 2 mU of recombinant
endoglycoceramidase II (Rhodococcus sp.) (rEGCase II)
(Takara-bio, Kusatsu, Shiga, Japan) was added to
release the lipid-bound glycans. After 24 h at 37°C,
another 2 mU was added and the sample was incubated
at 37°C for another 24 h. The purification of released
lipid-glycans was performed as described for the
N-glycans using RP C18- and carbon cartridges.
To support glycan structure assignments, part of the
isolated N-glycans and glycolipid-glycans were addi-
tionally treated with hydrofluoric acid (HF), which
removes labile substitutions including α1-3 linked
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fucoses. All isolated glycans were labelled with 2-ami-
nobenzoicacid and purified by Biogel P10 (Bio-Rad,
Hercules, CA, USA). The labelled glycans were mea-
sured by MALDI-TOF-MS with 2,5-dihydroxybenzoic
acid (Bruker Daltonics, Bremen, Germany) as matrix
using UltrafleXtreme mass spectrometers (Bruker
Daltonics) in the negative-ion reflectron mode. When
necessary, samples were cleaned up with ZipTip C18
(Merck Millipore, Burlington, MA, USA) before
MALDI-TOF-MS. The obtained mass spectra were
smoothed and the base-line was subtracted using
FlexAnalysis (version 3.4, Bruker Daltonics). Glycan
compositions were identified from the peak lists using
GlycoWorkbench (Version 3) [36]. Peaks with a signal
to noise ratio below 2 were excluded and masses are
registered as deprotonated [M-H]−. 2-AA was taken
into account as a fixed reducing-end modification.
For the interpretation of the relative most abundant
signals for spectral assignments we used (when avail-
able) previously published structural data from
S. mansoni glycans [35]. In the spectra, the structure
of the most likely or most abundant isomer of the
composition is indicated.
RNA extraction and qPCR analysis
HumanmoDCs were pre-incubated with or without αDC-
SIGN,αMR, or IgG1 isotype and stimulatedwith IL-1β and
TNF-α and schistosomula EV-enriched preparations as
described above. After 6 h stimulation at 37°C and 5%
CO2, cells were stored on ice for 10min, harvested, washed
with cold PBS, snap frozen, and stored at −80°C till RNA
extraction. RNA was extracted with the RNeasy Kit
(Qiagen, Hilden, Germany) according to the manufac-
turer’s protocol. RNA was quantified using NanoDrop
1000 Spectrophotometer (Thermo Fisher Scientific) and
cDNA synthesis was performed on 0.2 µg RNA according
to standard procedures. Primer Express (Applied
Biosystems, Waltham, MA, USA) was used to design pri-
mers that were synthesized by Biolegio (Nijmegen, The
Netherlands). Sequences of the primers were: β-
actin_Forward(F): 5ʹ- GCTACGAGCTGCCTGACGG-3ʹ;
β-actin_Reverse(R): 5ʹ- CAGCGAGGCCAGGATGGAG
CC-3ʹ; β-2-M_F: 5ʹ- TGCCGTGTGAACCATGTGA-3ʹ;
β-2-M_R: 5ʹ-CCAAATGCGGCATCTTCAA-3ʹ; RPLPO
_F: 5ʹ-GGCGACCTGGAAGTCCAACT-3ʹ; RPLPO_R: 5ʹ-
CCATCAGCACCACAGCCTTC-3ʹ; IL-10_F: 5ʹ-ACCT





TCTGGAGCA-3ʹ. Quantitative real-time PCR (qPCR)was
performed using CFX96 instruments (Bio-Rad
Laboratories) and CFX Maestro (Bio-Rad) software.
Technical duplicates with <1 Cq value difference were
averaged and gene expression was calculated with the
ΔΔCq method using the average Cq of the reference genes
β-actin, β-2-M, and RPLPO to normalize [37].
Statistical analyses
All data were analysed using a paired student t-test or
repeated measures One-way ANOVA (P values <0.05
were considered significant) with Tukey’s or Dunnett’s
Multiple Comparison Test in GraphPad Prism 5.0
(GraphPad Software, Inc., La Jolla, CA, USA).
Results
Cryo electron microscopy reveals ultrastructural
characteristics of schistosomula EVs
Schistosomula were cultured for 72 h and EV-enriched
preparations were obtained from schistosomula E/S by
sequential (ultra)centrifugation steps. TEM confirmed
isolation of vesicles in the size-range between 35 and
190 nm (Figure 1(a–b)). NTA analysis showed a size-
range of 30–650 nm with a minor peak around 40 nm
and three major peaks around 110, 160, and 350 nm
(Figure 1(c)). Culture medium without parasites that
was processed similarly (medium control) and PBS
alone only showed minor peaks between 60 and
150 nm as NTA background (Figure 1(c)). The average
particle concentration measured with NTA was
2.33E10/100,000 schistosomula and the average protein
concentration of EV-enriched preparations was 6 µg/
100,000 schistosomula.
Although the TEM images corresponded with pre-
vious observations [6], there was a discrepancy in the
sizes measured with the TEM and NTA. Therefore,
we additionally analysed the EV preparations with
cryo EM to visualise the near native state of the EVs
and measure their size (Figure 1(d)). Interestingly, the
cryo EM revealed thin filament-like structures cover-
ing the EV surface in 45.5% of all measured EV and
in >70% of EVs when excluding EVs smaller than
100 nm. The filamentous structures ranged from 10
to 340 nm in length (average length of 128.5 nm)
additional to the size of the EV diameter to the EV
membrane (Figure 1(e)). These surface structures were
most likely lost during the sample preparation for
negative stained TEM (Figure 1(a)) and thus not
observed, while NTA size measurement did include
these structures as shown by similar size ranges
between NTA and cryo EM.
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Figure 1. TEM, NTA and cryo EM measurement of schistosomula EVs.
EV-enriched preparations analysed by transmission electron microscopy at 60,000 × (a) and 120,000 × magnification (b). Scale bars are 200 nm. EVs
are pointed out with arrow heads, the small (<60 nm) structures (black arrows) in (b) are artefacts and were also observed in PBS only. In addition,
EVs were analysed by nanoparticle tracking analysis (NTA) (c). The graph shows the average of 17 schistosomula EV-enriched preparations (black
line), 10 medium controls (dark orange line), and 15 PBS (background) in which the preparations were resuspended (blue line), averages are shown
with SEM (lighter areas). Cryo EM of EVs at 13,500 × magnification (d). Scale bars are 500 nm. The EV membrane and stretch of the filamentous
structures are indicated in the middle pane with white dashed circles and black dashed circles, respectively. Right pane shows a close up of one EV
with filaments. Quantification of the EV sizes excluding (EV diameter) or including (EV diameter + filaments) the thin filaments from a total of 1056
EVs (e). EM pictures are representative for four biological replicates.
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Internalisation of schistosomula EV by human
moDCs is calcium dependent
To investigate the interaction of schistosomula EVs
with human moDCs, EVs were first labelled with the
fluorescent dye PKH26. MoDCs (0.25E6 moDC/mL)
were incubated with a maximum of 6E9 EV/mL,
which is equivalent to approximately 10 moDCs
receiving the number of EVs released by one schisto-
somulum during three days of culture. After 2 h of
incubation, there was a dose-dependent increase in EV
binding/uptake by the CD1a+ moDCs indicated by an
increased geometric mean fluorescence intensity
(geoMFI) relative to cells in medium only (Figure 2).
Furthermore, the fluorescence of cells incubated with
dye control was unchanged, indicating that the increase









































































































































































































































































Figure 2. Dose dependent uptake of schistosomula EVs by human moDC is temperature and calcium dependent.
Measured PKH26 fluorescence (PKH26 labelled EVs) of CD1a+ cells was obtained via gating as pictured in (a). The geoMFI (geometric mean
fluorescent intensity) of PKH26 is shown relative to unstimulated cells (b). MoDC from three donors. EV uptake visualized by confocal microscopy
(c). Images show maximum projections (top panels) and 3D visualizations (bottom panels) of recorded z-stacks of two different fields. PKH26-
labelled EVs are stained in red and the nuclei in blue (Hoechst). Selected pictures are representative for three donors. Human moDC incubated with
EVs with either EGTA added pre- or post-incubation (d). Confocal images of moDC pre-treated with EGTA followed by EV incubation (e). Scale bars
are 10 µm. Mean±SEM *p < 0.05, **p < 0.01, ***p < 0.001, using repeated measures ANOVA with Dunnett’s Multiple Comparison Test compared to
cells in medium only (b) or repeated measures ANOVA with Tukey’s Multiple Comparison Test (d). SSC-A, side-scatter; FSC-A, forward-scatter
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in MFI was due to binding/uptake of labelled EVs and
not due to dye aggregates [38]. EV binding/uptake by
moDCs did not change due to stimulation of the cells
with LPS or in the presence of IL-1β+TNF-α.
Incubation at 4°C instead of 37°C did not lead to
binding/uptake of EVs by the moDCs (Figure 2), sug-
gesting that the interaction with and uptake of the
schistosomula EVs by target cells are active processes.
We visually confirmed that EVs were internalised by
moDCs with confocal microscopy (Figure 2(c)).
MoDCs are known to express C-type lectin recep-
tors that bind glycan motifs present on schistosome E/S
components in a calcium dependent manner [39]. To
investigate whether moDCs also recognise schistoso-
mula EVs via CLR-glycan motif interactions, moDCs
were incubated with fluorescently labelled EVs in the
presence of the calcium chelator EGTA and subse-
quently analysed by flow cytometry and confocal
microscopy (Figure 2(d–e)). Pre-incubation of EGTA
almost completely abrogated the fluorescence signal
and EV internalisation of moDCs compared to EV-
exposed moDCs without EGTA pre-incubation, indi-
cating calcium dependent interaction with moDCs
such as CLRs. Next, when EGTA was added after
incubation with EVs in order to remove EVs bound
to CLRs, this resulted in only a minor reduction of
fluorescence signal (Figure 2(d)), confirming that most
of the EVs were internalised by moDCs rather than
bound to the surface.
Schistosomula EVs contain CLR ligands on their
surface
We next analysed the glycosylation of schistosomula
EVs to assess whether ligands for CLRs were present.
First, the overall N-glycan content of the EV-enriched
preparations was determined by mass spectrometry
(Figure 3(a)). MALDI-TOF mass spectra of PNGase
F released N-glycans were assigned based on the
detailed glycan structure descriptions available for
overall N-glycan preparations of S. mansoni schistoso-
mula [35]. Interestingly, the spectrum of N-glycans
from the EV preparation was highly similar to pre-
viously published spectra of total extracts of three-day
cultured schistosomula [24,35]. The major signals are
from oligomannosidic structures of complex glycans
with a core(α6)-fucose and one or two antennae con-
sisting of Galβ1–4GlcNAc (LacNAc, LN) and/or LeX.
Structures with a core-xylose modification or
GalNAcβ1–4GlcNAc (LacDiNAc or LDN) antennae
with five to nine fucose residues were observed at
relatively low levels (Figure 3(b)). These results show
that schistosomula EVs contain similar N-glycans as
previously found in total schistosomula extracts,
including LeX and oligomannose motifs, which are
both ligands for DC-SIGN and MR [21,23].
To identify specific N-glycans that might be available
for interaction with CLRs on the surface of EVs, we
treated intact EVs with PNGase F to release all (“surface”)
N-glycans that were accessible to the enzyme. MALDI-
TOF-MS analysis was performed on both the released
“surface” N-glycans as well as on the remaining
N-glycans of the PNGase F-treated (“shaved”) EVs
(Figure 3(c–d)), which likely represent glycans on the
inside of the EVs. Interestingly, the most abundantly
detected N-glycans on the EV surface contained one or
two LeX antennae (Figure 3(c)) while the major glycans
of the “shaved” EVs were the oligomannosidic structures
(Figure 3(d)). These results show that the glycoproteins
on the surface of schistosomula EVs carry a specific sub-
set of N-glycans with LeX motifs, which are potential
ligands for DC-SIGN or MR in the context of pathogen-
host interactions [19,40,41].
EVs are internalised via DC-SIGN but not MR or
DCIR
To investigate whether DC-SIGN or MR on moDCs
were involved in uptake of schistosomula EVs via gly-
can motifs on these EVs, moDCs were pre-incubated
with antibodies blocking DC-SIGN or MR and subse-
quently incubated with labelled schistosomula EVs for
2 h (Figure 4(a–b)). In addition we investigated EV
binding after blocking DCIR, a receptor expressed on
moDCs that does not bind LeX containing glycans but
has been shown to bind S. mansoni cercarial extract
[19]. Blocking DC-SIGN led to almost complete inhi-
bition of EV uptake while blocking the MR, DCIR, or
pre-incubation with the isotype control did not reduce
EV internalisation. Inhibition of EV internalisation
after DC-SIGN block was confirmed by confocal
microscopy (Figure 4(c)). This reveals that schistoso-
mula EVs were internalised by moDCs via DC-SIGN.
EV-associated glycolipid-glycans include DC-SIGN
ligands
Given that the EV surface contained DC-SIGN ligands,
including the LeX motif, we investigated whether EV
deprived from surface N-glycans by PNGase
F treatment would still be internalised by moDCs.
Interestingly, the PNGase F-treated EVs showed
a minor but not significant reduction in internalisation,
and the EV uptake could still be inhibited by blocking
DC-SIGN (Figure 5(a)). Since it has been shown that
cercariae produce glycolipid-glycans that contain LeX
8 M. E. KUIPERS ET AL.
and other potential DC-SIGN ligands [35,42], we addi-
tionally determined the total lipid-derived glycan profile
of the schistosomula EVs (Figure 5(b)). Here we detected
a heterogeneous set of highly α3-fucosylated glycolipid
structures, mostly similar to the glycolipid-glycans found
in total schistosomula extract [35]. Interestingly, these


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3. Schistosomula EV-surface N-glycans include DC-SIGN ligands.
Basic scheme of the protocol for obtaining the N-glycan spectra (images adjusted from Servier Medical Art) (a), details can be found in the materials
and methods. PNGase F released N-glycans measured by MALDI-TOF-MS from total (b), intact (PGNase F accessible N-glycans, “surface”) (c), and
PNGase F treated (PGNase F non-accessible N-glycans on either surface or inside of the EV, “shaved”) (d) EV-enriched preparations. Signals are
labelled with monoisotopic masses. Putative structural assignments were deduced from these masses based on hydrofluoric acid (HF) treatment
(data not shown) and published data of schistosomula glycans [34]. Spectra shown are representative for three biological replicates. Red triangle,
fucose; yellow circle, galactose; green circle, mannose; blue square, N-acetylglucosamine; yellow square, N-acetylgalactosamine; white star, xylose;
*, signals corresponding to a hexose oligomer of unknown origin; #, non-glycan signals
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(LeY)) and GalNAcβ1–4(Fucα1–3)GlcNAc (LDN-F)
(Figure 5(b) insert), which are all previously described
ligands of DC-SIGN [42,43]. These data suggest that
additional to surface N-glycans, EV-associated lipid-
glycans play a role in interaction with DC-SIGN.
Schistosomula EVs induced increased cytokine
release and costimulatory molecule expression on
moDCs
Next, we investigated whether incubation of moDCs
with schistosomula EVs affect their activation status
and cytokine production. We first incubated human
moDCs for 24 h with EV-enriched preparations but
observed no or very low release of cytokines. Therefore,
in addition to EVs, moDCs were co-cultured with IL-
1β and TNF-α, cytokines that are released by immune
cells upon schistosome infection [3], allowing us to
further investigate whether EVs could change the acti-
vation status of moDCs. Under these conditions, schis-
tosomula EVs significantly increased IL-6, IL-10 and
IL-12 secretion by moDCs (Figure 6(a)).
Furthermore, a significant upregulation of the costi-
mulatory molecules CD80, CD86 and regulatory surface
molecule PD-L1 was observed, while there was no sig-
nificant effect on CD40, HLA-DR and PD-L2 expression
(Figure 6(b)). These data suggest that the EV-enriched
preparations were mostly synergizing or augmenting
other inflammatory signals.
Role for DC-SIGN in EV-augmented immune
responses
Since schistosomula-derived EVs were mainly inter-
nalised via DC-SIGN, we hypothesized that inhibit-
ing this receptor would alter the observed augmented
immune responses of moDCs by the EVs. Blocking
DC-SIGN during a 24 h EV stimulation, however,
did not show a significant effect on IL-6, IL-10 and
IL-12 release (Figure 7(a)) nor on the expression of
the co-stimulatory surface markers CD80, CD86,
HLA-DR, PD-L1 and PD-L2 after 48 h stimulation
(Figure 7(b)). To understand why the blocking of
DC-SIGN did not consistently influence the
enhanced immune responses of moDCs by the EVs
whereas it almost completely blocked EV internalisa-
tion after 2 h, we studied EV uptake in the presence














































































Figure 4. Schistosomula EVs are internalised via interactions with CLR DC-SIGN.
PKH26 fluorescence of CD1a+ cells with indicated pre-incubations (x-axis). The geoMFI (geometric mean fluorescent intensity) is shown relative to
cells in medium only (a). MoDC from three to six donors. Representative histograms of two donors from same data plotted in a (b). Confocal
microscopy visualisation of EV uptake and inhibition of EV uptake when DC-SIGN was blocked (c). Images show maximum projections of recorded
z-stacks. PKH26-labelled EVs are stained in red and the nuclei in blue (Hoechst). Scale bar is 10 µm. Selected images are representative for three
donors. Mean±SEM ***p < 0.001, using repeated measures ANOVA with Tukey’s Multiple Comparison Test. MR, mannose receptor
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incubation. Blocking of DC-SIGN significantly
reduced EV internalisation after 48 h (Figure 7(c)).
However, the vast majority of the moDCs were still
positive for the fluorescent dye, although the fluor-
escent intensity was lower when DC-SIGN was
blocked (Figure 7(d)). Possibly other mechanisms
than those mediated by DC-SIGN play a role in EV
internalisation by moDCs after prolonged exposure.
To investigate whether blocking of DC-SIGN does
interfere with moDC function during shorter incuba-
tions with schistosomula-derived EVs, moDCs were
stimulated with EVs in the absence or presence of
blocking antibodies for 6 h, after which cytokine
mRNA expression was determined. Indeed, at this
time point, the effect of blocking DC-SIGN was
more prominent with a significant reduction in
TNF-α mRNA and a trend for lower IL-10 mRNA
expression (Figure 7(e)). IL-12p35 mRNA levels were
also reduced in most donors, though not significant.
These results show that, within the first hours of
exposure but not at a longer timescale, the moDC
immune profile is influenced by schistosomula EVs
through internalisation via DC-SIGN.
Discussion
Schistosome parasites are master regulators of host

















































































































































































































































































































































































































































































































































































































































































LeX pseudo-LeY F-LDN LDN-F F-LDN-F
Figure 5. Internalisation of schistosomula EVs without surface N-glycans via DC-SIGN and EV-associated glycolipid-glycans.
The geoMFI (geometric mean fluorescent intensity) of PKH26 relative to unstimulated moDC after 2 h incubation with labelled EVs that were
treated without or with PNGase F (a). Pre-incubations are indicated on the x-axis. MoDC from 3 donors. Mean±SEM *p < 0.05, ***p < 0.001, using
repeated measures ANOVA with Tukey’s Multiple Comparison Test. EV-derived glycolipid-glycans measured by MALDI-TOF-MS (b). Signals are
labelled with monoisotopic masses. Putative structural assignments were deduced from these masses based on published data of schistosomula
glycans [34] and on hydrofluoric acid (HF) data (not shown). Coloured bars indicate the corresponding core structure with varying numbers of
fucose substitutions. Putative terminal motifs formed by these fucoses are indicated in the insert. The spectrum shown is representative for three
biological replicates. Red triangle, fucose; yellow circle, galactose; blue square, N-acetylglucosamine; yellow square, N-acetylgalactosamine; LeX,
LewisX; LeY, LewisY; F-LDN/LDN-F/F-LDN-F, fucosylated LacDiNAc *, signals corresponding to a hexose oligomer of unknown origin; #, non-glycan
signals
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and products to achieve this. Here we demonstrate that
S. mansoni schistosomula release EVs that contain LeX
antigens on their surface. Interaction of the glycosylated
EVs with DC-SIGN on moDCs lead to internalisation
and enhanced expression of both immunostimulatory





















































































































































Figure 6. Schistosomula EVs augment moDC immune responses.
Released cytokines (a) and surface marker expression (b) of moDC incubated with EVs. The control is medium without parasites that has been
cultured and processed exactly like the schistosomula EVs. Data points are shown as fold change relative to moDC with IL-1β and TNF-α for that
specific donor. MoDC from 7 to 11 donors. Mean±SEM ***p < 0.001, using repeated measures ANOVA with Dunnett’s Multiple Comparison Test

































































































































































































































































































Figure 7. Role for DC-SIGN in augmented immune responses by schistosomula EVs.
Released cytokines (a) and surface marker expression (b) of moDC with indicated pre-incubations (x-axes) before EV incubation. Linked points
represent data from one donor. Data is shown as fold change relative to moDC with IL-1β and TNF-α from that specific donor (n = 7). Summary of
geometric mean fluorescent intensity (geoMFI) of moDC incubated with PKH26-labelled EVs for 48 h, relative to medium control (c) (n = 6).
Histograms of moDC from one representative donor from data plotted in c (d). Relative expression of mRNA from moDC after 6 h EV incubation and
indicated pre-incubations (x-axes) (e) (n = 5). *p < 0.05, ***p < 0.001, using repeated measures ANOVA with Tukey’s Multiple Comparison Test (c) or
paired student t-test (a, b, e)
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EVs appear to contribute to immune modulation by the
parasite.
Schistosomula are multicellular organisms, having
various organs and cells as potential sources of their
released EVs. It has been shown that micron-sized vesi-
cles are released from their acetabular glands [11,44] and
it is suggested that EVs can also derive from the tegument
[6]. Since multicellular organisms release heterogeneous
populations of EVs, it is likely that the moDCs can inter-
nalise these EVs via various receptors and/or routes [13].
The schistosomula-derived EV populations described
here were heterogeneous in size, which we analysed
with NTA (Figure 1(c)) and cryo EM (Figure 1(e)). The
size of EVs may influence uptake routes, as has been
shown for Helicobacter pylori outer membrane vesicles
(OMVs): small OMVs were taken up via caveolin-
mediated endocytosis and bigger OMVs via micropino-
cytosis and endocytosis [45]. The major population of
EVs >300 nm we observed have not been described
before for S. mansoni schistosomula [6]. Although we
used a similar schistosomula EV isolation protocol as
Nowacki et al [6], the isolated EVs in that paper were
only visualised by TEM of negatively stained EVs and not
by NTA. With this same technique, our isolated schisto-
somula EVs also showed similar sizes <200 nm
(Figure 1(a–b)) but only with the NTA and cryo EM the
EV population >300 nm was detectable. EVs >300 nm
have not been found among adult worms EVs [7,8,46].
Schistosomes are organisms with a complex life cycle and
the schistosomula and adult worm life stages differ in size,
shape, molecular, and cellular make up, and interaction
with the host and its immune system [2,47]. Therefore, it
is likely that different life stages of the parasite produce
different EV populations regarding molecular content
[6,48] as well as size. Furthermore, the adult worm EVs
published have been isolated by different protocols which
may further explain differences between the observed
sizes of EVs derived from various schistosome different
life stages.
Interestingly, our cryo EM data showed that around
half of the schistosomula-derived EVs were covered
with thin filament-like structures (Figure 1(d)). These
structures have not been described for eukaryotic EVs
so far. It remains to be explored what the molecular
composition of these EV-associated structures is and
whether these structures are specific for S. mansoni
and/or specifically related to the schistosomula life
stage. These thin filaments resemble the electron-
dense surface layer of extracellular proteins and LPS
or glycocalyx on some bacteria [49,50] and their
released OMVs [51]. We hypothesize that the struc-
tures on schistosomula EVs are composed of large,
complex glycoconjugates and/or include proteins with
attached glycan polymers, similar to the mammalian
glycocalyx consisting of proteoglycans with attached
glycosaminoglycans [25]. Altogether, the EM analyses
emphasize that cryo EM provides improved visualisa-
tion of the near native state of isolated EVs compared
to TEM of negatively stained EVs.
EVs released by S. mansoni schistosomula were
internalised by human moDCs (Figure 2). Previous
studies have demonstrated that S. japonicum EVs
derived from adult worms and eggs are also interna-
lised by host cells [46,52–54]. This indicates, together
with our data, that at least three lifecycle stages of
Schistosoma in humans release EVs that interact with
the host. By chelating extracellular calcium with EGTA,
schistosomula EV could not bind to or be taken up by
the moDC (Figure 2(d–e)). This suggests that the inter-
action of the EVs with the moDC was via the ligation
of glycoconjugates to CLRs, which is calcium depen-
dent, and not via protein-protein interaction. By inhi-
biting specific CLRs we show that internalisation of
schistosomula EVs by moDCs is primarily facilitated
by DC-SIGN (Figure 4). This CLR is known to bind
schistosome egg [21], cercarial [43], and worm antigens
[55], via glycan motifs including mannotriose, LeX,
LDN-F, and pseudo-LeY [19,42,43]. In contrast, CLR
DCIR mainly binds LeB (LewisB) and sulpho-LeA
(LewisA) motifs [19], and indeed, blocking this recep-
tor did not reduce EV uptake by the moDC. Previously,
it was shown that the egg-derived glycoprotein omega-
1, which carries LeX containing N-glycans highly simi-
lar to those found here on the EVs (Figure 3), is mainly
internalised by moDCs via the MR [22]. However,
when blocking the MR, EV internalisation was not
inhibited. This difference of internalisation routes
between omega-1 and EVs could be explained by the
characteristics of the two CLRs: DC-SIGN has one
carbohydrate recognition domain (CRD), is present as
tetramers, and it clusters in (lipid raft) nanodomains
that are distributed on the cell membrane. Clustering
increases the avidity of low affinity glycan-lectin inter-
actions and allows this receptor to interact at multiple
sites with pathogens that differ greatly in size [56]. On
the other hand, the MR consists of multiple CRDs,
which results in binding of multivalent or repetitive
ligands to a single MR monomer [57]. Considering
these aspects, larger particles such as EVs would favour
DC-SIGN mediated uptake while smaller glycosylated
proteins are more likely to be internalised via other
receptors, such as the MR. A very recent publication
substantiates this theory by showing that tumour-
derived apoptotic EVs with high-mannose glycans on
their surface were mainly internalised via interaction
with DC-SIGN and not the MR [58]. Furthermore, it
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suggests that, together with our findings, DC-SIGN
mediated EV uptake may be a widely occurring
mechanism, across a broad spectrum of species and
may not be exclusive to schistosomula-derived EVs.
Of note is that helminths, including S. mansoni, lack
sialic acid in their glycan repertoire, which is
a fundamental difference with mammalian glycans. It
was recently found that EVs released by human glio-
blastoma cells had complex sialic acid-capped
N-glycans on their surface that mainly bound to
Siglec-9 on moDCs [59]. When sialic acids on the EV
surface were enzymatically removed and LeY was
inserted, EV uptake by moDC and binding of the
EVs to DC-SIGN were increased. Furthermore, EVs
from murine hepatic cell lines expose sialyl-LeX on
the EV surface and removing the sialic acids with
neuraminidase significantly increased EV uptake by
M1 cell lines [28]. However, no DC-SIGN blocking
experiments were performed in these studies. Thus,
the question remains whether EV internalisation via
DC-SIGN is specific for schistosomula EVs, or whether
it is a more general mechanism via which EVs from
both pathogens and mammalian cells are internalised.
However, we cannot exclude the possibility that inter-
nalisation of schistosomula EVs may be facilitated via
different CLRs in a different host. For example, the
murine macrophage galactose-type lectin (MGL-1)
can bind to LeX [60] while the human MGL cannot
[61]. Human MGL binds to LDN motifs, which were
absent in our schistosomula EV glycan analyses.
So far, most research on glycosylation of pathogen-
derived EVs focussed on lipopolysaccharides of bacterial
OMVs [62–65]. Only very recently, the presence of gly-
coconjugates on the surface of EVs released by the hel-
minth Fasciola hepatica was studied using lectin
microarrays [66]. Here we performed a more detailed
structural analysis of glycans associated with EVs released
by a helminth parasite. Using mass spectrometry we
showed the presence of mainly complex type N-glycans
with LeX motifs as well as oligomannose and high man-
nose glycans (Figure 3(b)) and the presence of lipid-
linked glycans with LeX, pseudo-LeY, and other
α3-fucosylated glycan motifs (Figure 5(b)). The EV
N-glycan profile was qualitatively very similar to that of
whole schistosomula [35]. The overall glycosylation pat-
tern associated with this particular schistosome life stage
was reflected in the EVs, however, with differences in
relative abundances of the glycans. Biological replicates
of the parasite culture and EV isolation generated at two
different laboratories (Leiden and Aberystwyth) showed
similar N-glycan profiles, confirming the reproducibility
of the EV isolation protocol and glycan patterns [6].
Mostly complex glycans with LeX motifs were cleaved
from intact EVs by incubation with PNGase-F (Figure 3
(c)), implicating that these structures were on the EV
surface. Glycoconjugates on the EV surface can influence
their cellular internalisation, as was shown for bacterial
OMV [65], murine hepatic cell line EVs [28], tumour-
derived EVs [58,59] and F. hepatica adult worm EVs [66].
Interestingly, PNGase F treated EVs were still internalised
by moDC via DC-SIGN (Figure 5(a)). This indicates that
other glycans with DC-SIGN ligands such as the fucosy-
lated lipid-linked glycans play a role in this process, either
specifically or in addition to the N-glycans. Mass spectro-
metry analysis showed the presence of EV-associated
glycolipid-glycans (Figure 5(b)) containing several struc-
tures that were reported previously for schistosomula
[35], but with more extended higher molecular weight
structures. Our data indicate that many of the EV lipid-
derived glycans contain motifs such as LeX, pseudo-
LeY and other α3-linked fucose containing motifs that
can bind to DC-SIGN [42,43], which may explain why
PNGase-F treated EVs could still be internalised via DC-
SIGN. Furthermore, S. mansoni produce various
O-glycans [35], which are possibly also present on EVs
and contribute to EV-CLR interaction. We therefore
suggest that both N-glycans and glycolipid-glycans, and
possibly O-glycans, contribute to the interaction of the
EVs with DC-SIGN. This interaction is most likely via
LeX motifs, which are abundant in these glycan types,
with the possible contribution of other α3-fucosylated
lipid-glycans.
Interestingly, the complex type N-glycans on the EV
surface and many of the glycolipids of the schistosmula
EVs contain antigenic glycan motifs that were pre-
viously shown to be the target of antibodies of various
isotypes during schistosome infection. These motifs
include N-glycan core-xylose, LeX, and the various
fucosylated glycolipid motifs [67–69]. It is therefore
tempting to speculate that EVs can either elicit these
antibodies and/or that EVs are targeted by antibodies
generated against other, similarly glycosylated, antigens
produced by schistosomes during an infection.
Antibodies that recognize and bind molecules on the
EV surface can facilitate internalisation by APCs, for
example via Fc receptors. Antibody-bound EVs can be
targeted to different intracellular compartments com-
pared to EVs without antibodies. This has been
observed for EVs from the helminth Heligmosomoides
polygyrus [70]. H. polygyrus EVs pre-incubated with
antisera were targeted to lysosomes. However, lyso-
some targeting has also been observed for antigens
internalised by DC-SIGN [71]. Another possibility is
that EV uptake is enhanced after incubation with anti-
sera, which was observed for F. hepatica EVs and
RAW264.7 macrophages [66]. Differences in route of
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uptake can possibly alter the fate of the EVs and thus
possibly influence EV-induced immunomodulation.
Cross-species communication via EVs that contri-
butes to modulation of host immune responses has
been described previously for helminths, including
H. polygyrus [70] and Nippostrongylus brasiliensis
[72]. In this study, we observed that S. mansoni schis-
tosomula EVs are capable of augmenting activation-
induced cytokine secretion and surface molecule
expression by human moDCs, including both immu-
nostimulatory and regulatory factors (Figure 6). It has
been suggested that a delicate balance between benefit
for the host and benefit for the parasite contributes to
overall survival of the parasite within the host with
limited pathology [3]. The induction of pro-
inflammatory cytokines is a natural response of the
host to the skin-invading pathogen, however, this
response is transient. Priming of a protective adaptive
immune response is hampered, probably via the induc-
tion of regulatory responses by the parasite, such as
increased IL-10 release and PD-L1 expression [12],
allowing the parasite to develop into mature worms
and start egg laying. Different molecules present in
the heterogenous EV population may have contributed
to the observed augmented immune responses. It is
known that DC-SIGN signalling via fucose ligands,
which are motifs found on the N-glycan and lipid-
glycan structures of the EVs, mainly increases IL-10
and decreases pro-inflammatory responses [73]. In
contrast, we observed that blocking DC-SIGN actually
decreased pro-inflammatory TNF-α and IL-12 mRNA
and did not fully reduce the responses to baseline
(Figure 7(e)). Thus, it is likely to assume that schisto-
somula EVs contain a mix of various (glycosylated)
proteins and RNAs (amongst other biological mole-
cules, such as lipids [74]) that all may contribute to
a combined effect on host immunity [6]. Indeed, the
NTA data as well as the cryo EM show at least
a variation in EV size and with or without the thin
filaments, and it is tempting to speculate that these
different EVs may show variation in their surface gly-
can profile and may have specific activities on host
immunity. Interestingly, since total E/S from schisto-
somula increases IL-12, IL-6 and IL-10 release as well
as CD86 expression by mouse BMDCs [11], it is tempt-
ing to suggest that part of the effects of the E/S are
mediated by the EVs in that secretion.
In contrast to the strong blocking effect of anti-DC-
SIGN antibodies on EV internalisation (Figure 4 and
Figure 7(c)), however, blocking DC-SIGN did not sig-
nificantly alter EV-augmented immune responses dur-
ing prolonged stimulation (Figure 7(a–b)). The
variation we detected among donors in reduction or
increase of IL-10 release in the presence of blocking
DC-SIGN (Figure 7(a)) was also observed in another
study that examined glycan-mediated effects by larval
E/S [75]. These donor-specific variances could be asso-
ciated with intrinsic DC-SIGN levels, which vary highly
between and within donors [76]. Furthermore, residual
uptake of EVs via other processes such as (macro-)
pinocytosis or protein–protein interaction could still
have affected the immune activation of moDCs upon
prolonged culture (Figure 7(d)). Shorter incubation,
however, showed that part of the augmented immune
profile of moDCs by schistosomula EVs was indeed
dependent on interaction with DC-SIGN (Figure 7(e))
and provides evidence that interaction of glycans on
the EV surface with DC-SIGN does play a role in
immune modulation of host responses.
In conclusion, our study demonstrates that S. mansoni
schistosomula release glycosylated EVs that carry LeX,
pseudo-LeY, and other fucosylated motifs, and we reveal
a distinct role for DC-SIGN in glycan-mediated inter-
nalisation of EVs by host immune cells. This interaction
contributes to increased pro- and anti-inflammatory
responses, substantiating that EVs play a role in host
immune regulation by helminths to establish and control
infection. Future studies on how EV-associated mole-
cules contribute to immune modulation will further
our understanding of parasite–host interactions and
may provide insights for vaccine development.
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